Article | July 27, 2020

EU Compassionate Use Programs - Where's My Drug?

By Gavin Morgan, Senior Manager of Global Logistics; Uday Pathapati, Senior Manager of Clinical Project Management; and Tiago Mateus, Project Manager, Marken

Alternative Logistics Realizes Efficiencies For Clinical Studies In Asia Pacific Region

By its nature, EU compassionate use supply is needed urgently. This means packaging, labeling, and distribution must be executed rapidly and efficiently. Trial sponsors must know what issues to manage and need to select the transportation routes carefully, especially during COVID-19.

Distributing compassionate use material within Europe has not been historically challenging, but the COVID-19 pandemic has created logistical obstacles including a decrease in transportation options and closed borders.

In this article our experts – Gavin Morgan, Senior Manager of Global Logistics, Uday Pathapati, Senior Manager of Clinical Project Management and Tiago Mateus, Project Manager from Marken – describe the logistical and distribution risk management factors that need to be considered when planning an EU Compassionate Use Program.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: